International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing
暂无分享,去创建一个
K. Bailey | M. Bell | M. Jeong | M. Farkouh | S. Goodman | A. Lerman | C. Rihal | M. Madan | J. Bae | Ivan J. Chavez | N. Pereira | V. Mathew | R. Lennon | J. Graham | L. Baudhuin | S. Kim | D. So | A. Hasan | Fearghas O'Cochlain | Nicole M. Pauley | Ahmed A Hasan
[1] Iyn-Hyang Lee,et al. Awareness and attitude of the public toward personalized medicine in Korea , 2018, PloS one.
[2] Joshua C Denny,et al. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention. , 2018, JACC. Cardiovascular interventions.
[3] Jeffrey L. Anderson,et al. Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial , 2017, JAMA.
[4] Brittany A. Borden,et al. Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program , 2017, Clinical pharmacology and therapeutics.
[5] M. Subramaniam,et al. Clinicians' perceptions of pharmacogenomics use in psychiatry. , 2017, Pharmacogenomics.
[6] Carolyn R Rohrer Vitek,et al. Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol , 2016, Genetics in Medicine.
[7] J. Wardle,et al. Genetic testing and personalized ovarian cancer screening: a survey of public attitudes , 2016, BMC Women's Health.
[8] D. Sargent,et al. Genotype-based clinical trials in cardiovascular disease , 2015, Nature Reviews Cardiology.
[9] A. Stewart,et al. Clinical Implementation of Cardiovascular Pharmacogenomics. , 2015, Mayo Clinic proceedings.
[10] Maurizio Fava,et al. Pharmacogenetic-guided psychiatric intervention associated with increased adherence and cost savings. , 2014, The American journal of managed care.
[11] M. McGuire,et al. Risk Management and Healthcare Policy Dovepress Adherence and Health Care Costs , 2022 .
[12] Beth A. Glenn,et al. Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. , 2012, Ethnicity & disease.
[13] Julianne M. O’Daniel,et al. Survey of U.S. Public Attitudes Towards Pharmacogenetic Testing , 2011, The Pharmacogenomics Journal.
[14] Y. Jang,et al. Association of cytochrome P450 2C19*2 polymorphism with clopidogrel response variability and cardiovascular events in Koreans treated with drug-eluting stents , 2011, Heart.
[15] D. Roter,et al. Patient reactions to personalized medicine vignettes: An experimental design , 2011, Genetics in Medicine.
[16] J. Ferrières,et al. Genetic determinants of response to clopidogrel and cardiovascular events. , 2009, The New England journal of medicine.
[17] Jaekyu Shin,et al. Survey on warfarin pharmacogenetic testing among anticoagulation providers. , 2009, Pharmacogenomics.
[18] R. Weinshilboum,et al. Cardiovascular pharmacogenomics and individualized drug therapy , 2009, Nature Reviews Cardiology.
[19] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[20] E. Antman,et al. Cytochrome p-450 polymorphisms and response to clopidogrel. , 2009, The New England journal of medicine.
[21] A. Issa,et al. Assessing Patient Readiness for the Clinical Adoption of Personalized Medicine , 2009, Public Health Genomics.
[22] J. Jankovic,et al. Comparing knowledge and attitudes towards genetic testing in Parkinson's disease in an American and Asian population , 2007, Journal of the Neurological Sciences.
[23] J. Brockmöller,et al. Patients' and physicians' perspectives on pharmacogenetic testing. , 2006, Pharmacogenomics.
[24] I. Björnsdottir,et al. A lay prescription for tailor-made drugs--focus group reflections on pharmacogenomics. , 2005, Health policy.
[25] Jane Wardle,et al. Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. , 2004, Preventive medicine.
[26] A. Aro,et al. Does Knowledge Make a Difference? The Association Between Knowledge About Genes and Attitudes Toward Gene Tests , 2000, Journal of health communication.